Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 7/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4449868 | 0.98 | ALDH1A1 (0.40) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL4453606 | 0.96 | ALDH1A1 (0.41) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL13550973 | 0.84 | ALDH1A1 (0.33) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL13550972 | 0.83 | ALDH1A1 (0.33) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL13914911 | 0.81 | TSHR (0.38) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL11921716 | 0.78 | TSHR (0.42) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL3843274 | 0.78 | TSHR (0.45) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL13550970 | 0.78 | TSHR (0.35) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL3843310 | 0.76 | TSHR (0.43) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL725889 | 0.76 | TSHR (0.43) | ALDH1A1TP53HIF1ACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099326-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND ANTIREFLECTION FILM | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090099326-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND ANTIREFLECTION FILM | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090099326-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND ANTIREFLECTION FILM | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090061360-A1 | MATERIAL FOR RESIST PROTECTIVE FILM FOR IMMERSION LITHOGRAPHY | ASAHI GLASS COMPANY, LIMITED (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-2014639-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND ANTIREFLECTION FILM | Idemitsu Kosan Co., Ltd. (JP) | 2009-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099326-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND ANTIREFLECTION FILM | ADGRF1, RFT1, AFF1 | ALDH1A1 282/4885TP53 4281/4885HIF1A 2125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.